CORE--HYBRIDOMA FACILITY

Project: Research project

Project Details

Description

The Hybridoma Facility will be housed in the Biohazard Facility where it will make and human monoclonal antibodies that react with HIV and its components. It will also carry out serological analysis on potentially biohazardous material.
StatusFinished
Effective start/end date10/1/879/30/93

Funding

  • National Institute of Allergy and Infectious Diseases

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.